The possibility of a cover-up of a surgical tool that many accuse of spreading cancer in women has drawn the attention of the FBI. Investigators have reportedly begun interviewing witnesses to examine the possibility that several parties, including medical device makers like Johnson & Johnson, failed to report the defect to authorities.
On July 30, Johnson & Johnson, the most prolific manufacturer of laparoscopic power morcellators used in hysterectomy procedures, announced its intentions to pull these devices from operating rooms. The following day, Johnson & Johnson released a letter to doctors around the world advising them to cease using their laparoscopic power morcellators, and to return the devices to the company.
A hearing in the courtroom of the MDL Judge supervising the federal litigation in the DePuy hip cases has been scheduled in Toledo, Ohio, next Tuesday, November 19, 2013.
A number of unsubstantiuated report s have recently appeared in the mass media regarding settlement of the DePuy/Johnson and Jonson ASR hip litigation.
Pharmaceutical giant Johnson & Johnson may have to pay over $1.8 billion to settle claims related to its marketing of its blockbuster antipsychotic drug Risperdal. The drug was once Johnson & Johnson's best-selling drug, generating over $24 billion in 2003.